When analyzing the human control cases, a hormone receptor-positive, HER2-negative status was confirmed by our central tumor grade and IHC; two cases presented luminal A-like tumors, and three presented luminal B-like breast cancer. This evidence concerns the gene ERBB2 and neoplasm.